Drug Shortage Report for APO-OMEPRAZOLE

Last updated on 2024-03-01 History
Report ID 219180
Drug Identification Number 02245058
Brand name APO-OMEPRAZOLE
Common or Proper name OMEPRAZOLE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) OMEPRAZOLE
Strength(s) 20MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 500 BTL
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-06
Estimated end date 2024-04-05
Actual end date
Shortage status Actual shortage
Updated date 2024-03-01
Company comments 100 BTL available
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2024-03-01 French Compare
v3 2024-03-01 English Compare
v2 2024-02-09 French Compare
v1 2024-02-09 English Compare

Showing 1 to 4 of 4